Insitro

Insitro: Series D Funding Round

Insitro has successfully raised $400M in Series D funding, reaching a valuation of $2.8B.

Company Overview

Machine learning for drug discovery

Funding Details

The Series D round was led by Blackstone, with participation from Canada Pension Plan Investment Board, Arch Venture Partners, Foresite Capital, GV, Andreessen Horowitz.

Company Information

• Headquarters: 279 East Grand Avenue, South San Francisco, CA 94080
• Founded: 2018
• Employees: 300+
• Category: Biotech

Investment

Insitro plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

• Blackstone: Verified investor in Series D
• Canada Pension Plan Investment Board: Verified investor in Series D
• Arch Venture Partners: Verified investor in Series D
• Foresite Capital: Verified investor in Series D
• GV: Verified investor in Series D
• Andreessen Horowitz: Verified investor in Series D